Skip to content
value.today

Apnimed, Inc.

Total raised
$249 M
7 rounds on record
Latest round
$25 M
Mar 2026
First round on record
Jun 2018
Today
Went public
See the company page

Apnimed, Inc. is listed today as Apnimed, Inc.: market value, financials and filings are on its company page.

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Apnimed, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$25 MNo. 7$10 to $50 million

Apnimed, Inc.: Raise no. 7, Mar 2026

Investors in this round

2 investors had bought by the notice of Mar 27, 2026: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry G. Wohl · Executive Officer
  • Dennis G. Molnar · Executive Officer
  • Lawrence G. Miller · Executive Officer, Director
  • Ramzi C. Benamar · Executive Officer
  • Chris C. Dimitropoulos · Director
  • Francois C. Beaubien · Director
  • Gary C. Sender · Director
  • Isaac C. Cheng · Director
  • Joseph C. Avellone · Director
  • Kevin C. Lind · Director
  • Paul C. Fonteyne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.”

Signed by Ramzi Benamar, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 27, 2026. Read the notice at the SEC.

equitySEC
Apr 2025$17 MNo. 6$10 to $50 million

Apnimed, Inc.: Raise no. 6, Apr 2025

Investors in this round

3 investors had bought by the notice of Apr 24, 2025: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry G. Wohl · Executive Officer
  • Dennis G. Molnar · Executive Officer
  • Lawrence G. Miller · Executive Officer, Director
  • Chris C. Dimitropoulos · Director
  • Francois C. Beaubien · Director
  • Gary C. Sender · Director
  • Isaac C. Cheng · Director
  • Joseph C. Avellone · Director
  • Kevin C. Lind · Director
  • Paul C. Fonteyne · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lawrence G. Miller, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2025. Read the notice at the SEC.

equitySEC
Dec 2022$80 MNo. 5$50 to $250 million

Apnimed, Inc.: Raise no. 5, Dec 2022

Investors in this round

6 investors had bought by the notice of Dec 23, 2022: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$80 M of $80 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry G. Wohl · Executive Officer
  • Dennis C. Molnar · Executive Officer, Director
  • Lawrence G. Miller · Executive Officer, Director
  • Michael G. Rogers · Executive Officer
  • Chris C. Dimitropoulos · Director
  • Isaac C. Cheng · Director
  • Joseph C. Avellone · Director
  • Ruoxi C. Hu · Director
  • Stefan C. Larson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lawrence G. Miller, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 23, 2022. Read the notice at the SEC.

equitySEC
Apr 2022$63 MNo. 4$50 to $250 million

Apnimed, Inc.: Raise no. 4, Apr 2022

Investors in this round

14 investors had bought by the notice of Nov 1, 2022: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$63 M of $63 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry G. Wohl · Executive Officer
  • Dennis C. Molnar · Executive Officer, Director
  • Lawrence G. Miller · Executive Officer, Director
  • Michael G. Rogers · Executive Officer
  • Chris C. Dimitropoulos · Director
  • Isaac C. Cheng · Director
  • James C. Galeota · Director
  • Joseph C. Avellone · Director
  • Rosy C. Hu · Director
  • Stefan C. Larson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lawrence G. Miller, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 1, 2022. Read the notice at the SEC.

equitySEC
Mar 2021$25 MNo. 3$10 to $50 million

Apnimed, Inc.: Raise no. 3, Mar 2021

Investors in this round

3 investors had bought by the notice of Mar 25, 2021: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry G. Wohl · Executive Officer
  • Dennis G. Molnar · Executive Officer, Director
  • Lawrence G. Miller · Executive Officer, Director
  • Gerald G. Chan · Director
  • James G. Galeota · Director
  • Joseph C. Avellone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lawrence G. Miller, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 25, 2021. Read the notice at the SEC.

equitySEC
Mar 2020$15 MNo. 2$10 to $50 million

Apnimed, Inc.: Raise no. 2, Mar 2020

Investors in this round

1 investor had bought by the notice of Apr 7, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Wohl · Executive Officer
  • Dennis Molnar · Executive Officer, Director
  • Lawrence G. Miller · Executive Officer, Director
  • Gerald Chan · Director
  • Joseph Avellone · Director
  • Ron Farquhar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lawrence G. Miller, President and CEO. Source: SEC Form D, newest notice filed Apr 7, 2020. Read the notice at the SEC.

equitySEC
Jun 2018$26 MNo. 1$10 to $50 million

Apnimed, Inc.: Raise no. 1, Jun 2018

Investors in this round

12 investors had bought by the notice of Aug 7, 2019: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Apnimed, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barry Wohl · Executive Officer
  • Lawrence Miller · Executive Officer, Director
  • Dennis Molnar · Director
  • Gerald Chan · Director
  • Joseph Avellone · Director
  • Ron Farquhar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lawrence G. Miller, President and CEO. Source: SEC Form D and 3 amendments, newest notice filed Aug 7, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Apnimed, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2026).

    SEC Form D · Mar 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2026

That is all the official record says: Apnimed, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Apnimed, Inc. are on record.

Investors#

5 named in official filings. Open an investor to see everything it has backed.

Investors in Apnimed, Inc.
InvestorKindAmountRoundRoleSource
Alpha Wave Global, LPFund or asset managernot statednot statedHeld Series C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2026)SEC Form 3
Alpha Wave Ventures GP, LtdVenture capitalnot statednot statedHeld Series C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2026)SEC Form 3
Chimera Investment LLCFund or asset managernot statednot statedHeld Series C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2026)SEC Form 3
Lunate Holding RSC LtdCompanynot statednot statedHeld Series C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2026)SEC Form 3
Morningside Venture Investments LtdVenture capitalnot statednot statedHeld preferred stock, 10% owner (Form 3, 2026)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 14 investors.

Largest shareholders today

Institutions holding Apnimed, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Apnimed, Inc.
NameRoleNamed in
Barry G. WohlExecutive officerMar 2026
Dennis G. MolnarExecutive officerMar 2026
Lawrence G. MillerExecutive officerMar 2026
Ramzi C. BenamarExecutive officerMar 2026
Dennis C. MolnarExecutive officerDec 2022
Michael G. RogersExecutive officerDec 2022
Barry WohlExecutive officerApr 2020
Dennis MolnarExecutive officerApr 2020
Lawrence MillerExecutive officerAug 2019
Chris C. DimitropoulosDirectorMar 2026
Francois C. BeaubienDirectorMar 2026
Gary C. SenderDirectorMar 2026
Isaac C. ChengDirectorMar 2026
Joseph C. AvelloneDirectorMar 2026
Kevin C. LindDirectorMar 2026
Lawrence G. MillerDirectorMar 2026
Paul C. FonteyneDirectorMar 2026
Dennis C. MolnarDirectorDec 2022
Ruoxi C. HuDirectorDec 2022
Stefan C. LarsonDirectorDec 2022
James C. GaleotaDirectorNov 2022
Rosy C. HuDirectorNov 2022
Dennis G. MolnarDirectorMar 2021
Gerald G. ChanDirectorMar 2021
James G. GaleotaDirectorMar 2021
Dennis MolnarDirectorApr 2020
Gerald ChanDirectorApr 2020
Joseph AvelloneDirectorApr 2020
Ron FarquharDirectorApr 2020
Lawrence MillerDirectorAug 2019

Went public since 2026. Its SEC number is that of a company listed on a stock exchange.